Levonorgestrel-Ethinyl Estradiol as Contraception
Levonorgestrel-ethinyl estradiol combined oral contraceptives (COCs) are a safe and highly effective contraceptive option for women of reproductive age, with typical-use failure rates of approximately 5% and perfect-use failure rates of 0.1%. 1, 2
Recommended Formulation and Initiation
Start with a monophasic COC containing 30-35 μg ethinyl estradiol combined with levonorgestrel, as this is the preferred initial regimen recommended by adolescent medicine providers. 1
- Same-day initiation is recommended to maximize contraceptive protection 1
- Among low-dose formulations, no single preparation has proven superior, so selecting based on insurance formulary coverage is appropriate 1
- Ultra-low-dose formulations (0.03 mg ethinyl estradiol with 0.15 mg levonorgestrel) provide effective contraception with Pearl Index as low as 0.13 3
Contraceptive Effectiveness
COCs are among the most effective reversible contraceptive methods, with perfect-use pregnancy rates of 0.1% and typical-use rates of 5%. 2
- Effectiveness is optimized by regimens with shorter or no placebo intervals, particularly important for women who frequently miss pills 1
- Extended-cycle regimens may increase contraceptive effectiveness by maximizing ovarian suppression 1, 4
Safety Profile and Noncontraceptive Benefits
COCs are completely reversible with no negative effect on long-term fertility and represent one of the best-studied medications ever prescribed. 1
Key Safety Points:
- No increased risk of breast cancer with COC use 1
- Use for more than 3 years provides significant protection against endometrial and ovarian cancers 1
- Low-dose formulations (20 μg ethinyl estradiol) are safe in women with low thrombogenic potential but contraindicated in complex valvular disease 1
Noncontraceptive Benefits:
- Decreased menstrual cramping and blood loss 1
- Improvement in acne 1
- Particularly beneficial for anemia, severe dysmenorrhea, endometriosis, abnormal uterine bleeding, and bleeding diatheses 1
- May help conditions exacerbated cyclically including migraine without aura, epilepsy, and irritable bowel syndrome 1
Extended-Cycle Regimens
Extended or continuous-cycle COCs are particularly appropriate for women desiring amenorrhea or those with medical conditions worsened by menstruation. 1, 4
- The most common adverse effect is unscheduled breakthrough bleeding, which typically improves over time 1, 4
- These regimens eliminate hormone-free intervals, minimizing drug interactions and optimizing ovarian suppression 1
- Offer greater ovarian suppression and prevent endogenous estradiol production while maintaining highly effective, rapidly reversible contraception 4
Managing Missed Pills
One Pill Late (<24 hours):
- Take the late pill as soon as possible 1
- Continue remaining pills at usual time 1
- No backup contraception needed 1
One Pill Missed (24-48 hours):
- Take the most recent missed pill immediately 1
- Continue remaining pills at usual time (even if taking two pills same day) 1
- Use backup contraception or avoid intercourse until 7 consecutive days of pills taken 1
Two or More Pills Missed (>48 hours):
- Take the most recent missed pill immediately; discard other missed pills 1
- Use backup contraception or avoid intercourse until 7 consecutive days of pills taken 1
- If pills missed in last week of hormonal pills (days 15-21): omit hormone-free interval and start new pack immediately 1
- Consider emergency contraception if pills missed during first week and unprotected intercourse occurred in previous 5 days 1
Special Populations
Cardiovascular Disease:
- Low-dose formulations (20 μg ethinyl estradiol) are safe in women with low thrombogenic potential 1
- Contraindicated in complex valvular disease 1
- For high-risk cardiac patients (cyanotic heart disease, pulmonary vascular disease), levonorgestrel-releasing intrauterine device is safer 1
Emergency Contraception:
- Combined estrogen-progestin regimen (100 μg ethinyl estradiol plus 0.50 mg levonorgestrel, repeated after 12 hours) can be used for emergency contraception 1
- Less effective than ulipristal acetate or levonorgestrel-only formulations and associated with more nausea and vomiting 1
- Should be taken as soon as possible within 5 days of unprotected intercourse 1
Common Pitfalls to Avoid
- Do not use monthly injectables containing medroxyprogesterone in patients with heart failure due to fluid retention risk 1
- Counsel patients that extended-cycle regimens initially cause more breakthrough bleeding, which typically improves with continued use 1, 4
- Ensure patients understand the 7-day rule for backup contraception after missing pills 1
- Remember that even with one or two missed pills mid-cycle, breakthrough ovulation is unlikely with proper formulations 5